Team:Peking R/HumanPractice/Investigation2
From 2011.igem.org
(Difference between revisions)
Grasscliff (Talk | contribs) |
KeyboardKen (Talk | contribs) |
||
(8 intermediate revisions not shown) | |||
Line 13: | Line 13: | ||
top:319px; | top:319px; | ||
width:655px; | width:655px; | ||
- | height: | + | height:2123px; |
z-index:2; | z-index:2; | ||
font-family: "Comic Sans MS", cursive; | font-family: "Comic Sans MS", cursive; | ||
Line 19: | Line 19: | ||
color: #333; | color: #333; | ||
text-align: justify; | text-align: justify; | ||
- | background-color: # | + | background-color: #FFF; |
} | } | ||
.notbookmaintitle { | .notbookmaintitle { | ||
Line 102: | Line 102: | ||
position:absolute; | position:absolute; | ||
left:547px; | left:547px; | ||
- | top: | + | top:2403px; |
width:144px; | width:144px; | ||
height:28px; | height:28px; | ||
Line 109: | Line 109: | ||
.clickteam { | .clickteam { | ||
color: #000; | color: #000; | ||
+ | text-align: center; | ||
} | } | ||
a:link { | a:link { | ||
Line 133: | Line 134: | ||
height:1725px; | height:1725px; | ||
z-index:3; | z-index:3; | ||
- | text-align: | + | text-align: left; |
color: #000; | color: #000; | ||
+ | font-family: Georgia, "Times New Roman", Times, serif; | ||
} | } | ||
.mainbody { | .mainbody { | ||
Line 253: | Line 255: | ||
</div> | </div> | ||
<div id="apDiv4"> | <div id="apDiv4"> | ||
- | <p> | + | <p><br /> |
- | Question 5</p> | + | <span class="clickteam">Question 5</span> </p> |
- | <p><img src="https://static.igem.org/mediawiki/2011/7/73/PekingR_hp_Q5.png" width=" | + | <p class="clickteam"><img src="https://static.igem.org/mediawiki/2011/7/73/PekingR_hp_Q5.png" width="386" height="290" hspace="50" /></p> |
- | < | + | <p> |
- | + | </p> | |
- | + | <p> | |
- | + | B.Usually discard directly and occasionally process them properly(22.73%)</p> | |
- | + | <p>C.Usually process them properly but occasionally discard directly(21.59%)</p> | |
- | + | <p> D.Always properly process them separately with other waste(23.86%)</p> | |
- | + | <p> E.No special attention has been paid(15.91%)</p> | |
- | + | <p> </p> | |
- | + | ||
- | + | <p class="clickteam">Question 6</p> | |
- | + | <p class="clickteam"><img src="https://static.igem.org/mediawiki/2011/f/fd/PekingR_hp_Q6.png" width="476" height="239" hspace="50" /><br /> | |
- | + | ||
- | + | ||
- | + | ||
- | + | ||
- | < | + | |
- | + | ||
- | <p>Question 6</p> | + | |
- | <p><img src="https://static.igem.org/mediawiki/2011/f/fd/PekingR_hp_Q6.png" width=" | + | |
<br /> | <br /> | ||
Question 8</p> | Question 8</p> | ||
- | <p><img src="https://static.igem.org/mediawiki/2011/7/7c/PekingR_hp_Q8.png" width="500" height="360" hspace="50" /></p> | + | <p class="clickteam"><img src="https://static.igem.org/mediawiki/2011/7/7c/PekingR_hp_Q8.png" width="500" height="360" hspace="50" /></p> |
+ | <p class="clickteam">Question 9</p> | ||
+ | <p><img src="https://static.igem.org/mediawiki/2011/c/ca/PekingR_hp_Q9.png" alt="" width="500" height="328" hspace="50" /></p> | ||
+ | <p> </p> | ||
+ | <p> </p> | ||
<hr /> | <hr /> | ||
- | <p>< | + | <p> </p> |
- | </p> | + | <p class="clickteam"><br /> |
+ | </p> | ||
<p class="clickteam"> </p> | <p class="clickteam"> </p> | ||
</div> | </div> | ||
Line 288: | Line 287: | ||
<th width="31" bgcolor="#E9FEF0" class="clickteam" scope="col"><a href="https://2011.igem.org/Team:Peking_R/HumanPractice/Investigation">Prev</a></th> | <th width="31" bgcolor="#E9FEF0" class="clickteam" scope="col"><a href="https://2011.igem.org/Team:Peking_R/HumanPractice/Investigation">Prev</a></th> | ||
<th width="16" bgcolor="#E9FEF0" class="clickteam" scope="col"><a href="https://2011.igem.org/Team:Peking_R/HumanPractice/Investigation">1</a></th> | <th width="16" bgcolor="#E9FEF0" class="clickteam" scope="col"><a href="https://2011.igem.org/Team:Peking_R/HumanPractice/Investigation">1</a></th> | ||
- | <th width="18" bgcolor="# | + | <th width="18" bgcolor="#CCCCCC" class="clickteam" scope="col"><a href="https://2011.igem.org/Team:Peking_R/HumanPractice/Investigation2">2</a></th> |
<th width="15" bgcolor="#E9FEF0" class="clickteam" scope="col"><a href="https://2011.igem.org/Team:Peking_R/HumanPractice/Investigation3">3</a></th> | <th width="15" bgcolor="#E9FEF0" class="clickteam" scope="col"><a href="https://2011.igem.org/Team:Peking_R/HumanPractice/Investigation3">3</a></th> | ||
<th width="45" bgcolor="#E9FEF0"class="clickteam" scope="col"><a href="https://2011.igem.org/Team:Peking_R/HumanPractice/Investigation3">Next</a></th> | <th width="45" bgcolor="#E9FEF0"class="clickteam" scope="col"><a href="https://2011.igem.org/Team:Peking_R/HumanPractice/Investigation3">Next</a></th> | ||
Line 299: | Line 298: | ||
<th width="42" bgcolor="#E9FEF0" class="clickteam" scope="col"><a href="https://2011.igem.org/Team:Peking_R/HumanPractice/Investigation">Prev</a></th> | <th width="42" bgcolor="#E9FEF0" class="clickteam" scope="col"><a href="https://2011.igem.org/Team:Peking_R/HumanPractice/Investigation">Prev</a></th> | ||
<th width="17" bgcolor="#E9FEF0" class="clickteam" scope="col"><a href="https://2011.igem.org/Team:Peking_R/HumanPractice/Investigation">1</a></th> | <th width="17" bgcolor="#E9FEF0" class="clickteam" scope="col"><a href="https://2011.igem.org/Team:Peking_R/HumanPractice/Investigation">1</a></th> | ||
- | <th width="16" bgcolor="# | + | <th width="16" bgcolor="#CCCCCC" class="clickteam" scope="col"><a href="https://2011.igem.org/Team:Peking_R/HumanPractice/Investigation2">2</a></th> |
<th width="18" bgcolor="#E9FEF0" class="clickteam" scope="col"><a href="https://2011.igem.org/Team:Peking_R/HumanPractice/Investigation3">3</a></th> | <th width="18" bgcolor="#E9FEF0" class="clickteam" scope="col"><a href="https://2011.igem.org/Team:Peking_R/HumanPractice/Investigation3">3</a></th> | ||
<th width="44" bgcolor="#E9FEF0"class="clickteam" scope="col"><a href="https://2011.igem.org/Team:Peking_R/HumanPractice/Investigation2">Next</a></th> | <th width="44" bgcolor="#E9FEF0"class="clickteam" scope="col"><a href="https://2011.igem.org/Team:Peking_R/HumanPractice/Investigation2">Next</a></th> |
Latest revision as of 07:23, 5 October 2011
Template:Https://2011.igem.org/Team:Peking R/bannerhidden Template:Https://2011.igem.org/Team:Peking R/back2 Template:Https://2011.igem.org/Team:Peking R/Humanpracticebackground
Investigation of Antibiotic Use and
Related Biosafety Issues: What's
happening out there and further.
Question 5
B.Usually discard directly and occasionally process them properly(22.73%)
C.Usually process them properly but occasionally discard directly(21.59%)
D.Always properly process them separately with other waste(23.86%)
E.No special attention has been paid(15.91%)
Question 6
Question 8
Question 9